A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT03406507 · COMPLETED
Trial details
- NCT number
- NCT03406507
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-22
- Primary completion
- 2020-03-25
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.